{"entity":{"id":"tqb3454","kind":"drug","name":"TQB3454","aka":[],"tldr":"TQB3454 is an experimental small-molecule drug from Chia Tai Tianqing Pharmaceutical in phase 3 trials for biliary tract cancer, aimed at IDH1 / IDH2.","summary":"TQB3454 is a small-molecule drug developed by Chia Tai Tianqing Pharmaceutical. Its target is IDH1 / IDH2 (the sponsor names IDH1 (mutant)). The sponsor states: Selective inhibitor of mutant IDH1 enzyme, given as an oral tablet, being tested against placebo in advanced biliary tract cancer patients with IDH1 mutations. ClinicalTrials.gov describes the intervention as: TQB3454 is a selective IDH1 mutant enzyme inhibitor. It is the investigational product in 1 recruiting or active industry-led phase 2 and phase 3 interventional cancer trial, including the phase 3 study NCT05987358 (A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma), in biliary tract cancer. The largest, NCT05987358, plans to enrol 165 participants with primary completion expected 2026-12. Status reflects the highest phase registered on ClinicalTrials.gov; no efficacy results are recorded here.","status":"phase-3","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov: trials of TQB3454","url":"https://clinicaltrials.gov/search?intr=TQB3454"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["cholangiocarcinoma"],"sections":[],"technologies":[],"targets":["idh"],"drugs":[],"companies":["sino-biopharm"],"institutions":[],"pathways":[],"terms":[],"trials":["nct05987358"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor pipeline pages)","editedOn":"2026-09-11"},"modality":"small molecule (structure undisclosed or not yet in PubChem)","mechanism":"Selective inhibitor of mutant IDH1 enzyme, given as an oral tablet, being tested against placebo in advanced biliary tract cancer patients with IDH1 mutations.","approvals":[],"mechanismSteps":[],"toxicity":[],"access":[],"regulatoryEvents":[]},"route":"/drugs/tqb3454/","neighbours":{"cancer":[{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"}],"target":[{"id":"idh","kind":"target","name":"IDH1 / IDH2","route":"/targets/idh/"}],"company":[{"id":"sino-biopharm","kind":"company","name":"Sino Biopharmaceutical (Chia Tai Tianqing)","route":"/companies/sino-biopharm/"}],"trial":[{"id":"nct05987358","kind":"trial","name":"A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma","route":"/trials/nct05987358/"}]}}